Increased Sensitivity DNA Sequencing Uses a computer algorithm repeatedly to determine the next bases in a sequence as a function not only of a physical fluorescence measurement made at that position, but also as a function of the previously determined nearby bases in the same sequence. Novel Cationic Liposomes for Gene Therapy Novel liposomes that are 100-fold more effective than currently available liposomes. Novel Tumour Protective Gene Novel ubiquitin specific protease, USP21, which may provide protection against the formation of solid tumours. The major coat protein of polyoma virus has many advantages of viral gene therapy vectors but has no risk of transferring viral genetic information to recipient cells. Valveless Ventilators for Anaesthesia and Critical Care Ventilator technology with enhanced performance, and safety characteristics.
Design allows significant cost savings in production.
IC Innovations is the wholly-owned technology transfer company of Imperial College of Science, Technology and Medicine. It is pro-active in identifying research with commercial potential and in marketing new technologies to industry. IC Innovations contributes to the value of new technologies through its expertise in strategic patent protection, its knowledge of the College's research portfolio and of potential markets for new work. It also has experience in establishing start-up companies based on College technology. The College assigns its rights in novel technology to IC Innovations, which handles financial and legal arrangements so as to protect the College's tax position as a charity, and to ensure optimal benefit to the College and its research staff, for the IPR and expertise they provide.